ADRB3 and metabolic dysfunction-associated steatotic liver disease: Moreover, mutations in the gene encoding the β3-AR, ADRB3, have been correlated with insulin resistance, increased risk for obesity and diabetes, and nonalcoholic fatty liver disease in obese individuals (42–46).